Salesforce, Kohl’s and Agilent fall premarket; Foot Locker, Moderna rise
2024.05.30 07:43
Investing.com — U.S. stock fell sharply Thursday, with sentiment hit by ongoing concerns that stronger than expected economic growth and sticky inflation will severely delay rate cuts by the Federal Reserve.
Here are some of the biggest premarket U.S. stock movers today:
-
Salesforce (NYSE:) stock slumped 15% after the workplace software group unveiled current-quarter guidance that fell short of analysts’ estimates.
-
Walt Disney (NYSE:) stock fell 0.1% after CNBC reported that activist investor Nelson Peltz has offloaded his entire stake in the entertainment giant, raking in roughly $1 billion.
-
Moderna (NASDAQ:) stock rose 2.9% following a Financial Times report that said the U.S. government is nearing an agreement to fund a late-stage trial of the drug maker’s pandemic bird flu vaccine.
-
Foot Locker (NYSE:) stock rose over 13% after the retailer affirmed its guidance for 2024 as its turnaround plan showed signs of progress.
-
Dollar General (NYSE:) stock rose 4% after the discount retailer posted strong first-quarter earnings on demand from cash-strapped customers.
-
Kohl’s (NYSE:) stock slipped 20% after the department store chain reported an unexpected first-quarter loss and issued a 2025 profit warning.
-
American Eagle Outfitters (NYSE:) stock fell 6.8% after the apparel retailer’s fiscal first-quarter sales came in weaker than expected, even as revenue was 5% above the levels seen a year ago.
-
Pure Storage (NYSE:) stock rose 9.5% after the company posted strong first-quarter earnings, highlighting AI-driven demand for its data storage platform.
-
HP (NYSE:) stock rose 5.2% after the PC maker’s quarterly earnings beat estimates on improving demand, thanks in part to AI.
-
UiPath (NYSE:) stock slumped 30% after the software company announced that CEO Rob Enslin is resigning, to be replaced by co-founder Daniel Dines, who stepped down as co-CEO on Jan. 31.
-
Hormel Foods (NYSE:) stock rose 0.9% after the food company beat fiscal second-quarter profit expectations and raised its full-year outlook, seeing steady demand for higher-priced meat products.
-
Agilent (NYSE:) stock fell 13% after the healthcare equipment maker’s second-quarter revenue registered an 8.4% decline from the same period last year, with the company lowering its 2024 guidance.